Relaxed Replication of MtDNA: A Model with Implications for the Expression of Disease

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 1999 Mar 26

PMID 10090901

Citations 80

Authors

P F Chinnery

D C Samuels

Affiliations

Soon will be listed here.

Abstract

Heteroplasmic mtDNA defects are an important cause of human disease with clinical features that primarily involve nondividing (postmitotic) tissues. Within single cells the percentage level of mutated mtDNA must exceed a critical threshold level before the genetic defect is expressed. Although the level of mutated mtDNA may alter over time, the mechanism behind the change is not understood. It currently is not possible to directly measure the level of mutant mtDNA within living cells. We therefore developed a mathematical model of human mtDNA replication, based on a solid foundation of experimentally derived parameters, and studied the dynamics of intracellular heteroplasmy in postmitotic cells. Our simulations show that the level of intracellular heteroplasmy can vary greatly over a short period of time and that a high copy number of mtDNA molecules delays the time to fixation of an allele. We made the assumption that the optimal state for a cell is to contain 100% wild-type molecules. For cells that contain pathogenic mutations, the nonselective proliferation of mutant and wild-type mtDNA molecules further delays the fixation of both alleles, but this leads to a rapid increase in the mean percentage level of mutant mtDNA within a tissue. On its own, this mechanism will lead to the appearance of a critical threshold level of mutant mtDNA that must be exceeded before a cell expresses a biochemical defect. The hypothesis that we present is in accordance with the available data and may explain the late presentation and insidious progression of mtDNA diseases.

Citing Articles

Bayesian classification of OXPHOS deficient skeletal myofibres.

Childs J, Gomes T, Vincent A, Golightly A, Lawless C PLoS Comput Biol. 2025; 21(2):e1012770.

PMID: 39970187 PMC: 11838899. DOI: 10.1371/journal.pcbi.1012770.

Sequencing and characterizing human mitochondrial genomes in the biobank-based genomic research paradigm.

Luo L, Wang M, Liu Y, Li J, Bu F, Yuan H Sci China Life Sci. 2025; .

PMID: 39843848 DOI: 10.1007/s11427-024-2736-7.

Genetic landscape of primary mitochondrial diseases in children and adults using molecular genetics and genomic investigations of mitochondrial and nuclear genome.

Ambrose A, Bahl S, Sharma S, Zhang D, Hung C, Jain-Ghai S Orphanet J Rare Dis. 2024; 19(1):424.

PMID: 39533303 PMC: 11555972. DOI: 10.1186/s13023-024-03437-x.

Age-induced changes in skeletal muscle mitochondrial DNA synthesis, quantity, and quality in genetically unique rats.

Musci R, Fuqua J, Peelor 3rd F, Nguyen H, Richardson A, Choi S Geroscience. 2024; 47(1):851-862.

PMID: 39312152 PMC: 11872842. DOI: 10.1007/s11357-024-01344-4.

Dissecting the sequential evolution of a selfish mitochondrial genome in Caenorhabditis elegans.

Dubie J, Katju V, Bergthorsson U Heredity (Edinb). 2024; 133(3):186-197.

PMID: 38969772 PMC: 11349875. DOI: 10.1038/s41437-024-00704-2.

References

Clayton D . Mitochondrial DNA gets the drift. Nat Genet. 1996; 14(2):123-5. DOI: 10.1038/ng1096-123. View

Larsson N, Clayton D . Molecular genetic aspects of human mitochondrial disorders. Annu Rev Genet. 1995; 29:151-78. DOI: 10.1146/annurev.ge.29.120195.001055. View

Ankel-Simons F, Cummins J . Misconceptions about mitochondria and mammalian fertilization: implications for theories on human evolution. Proc Natl Acad Sci U S A. 1996; 93(24):13859-63. PMC: 19448. DOI: 10.1073/pnas.93.24.13859. View

Weber K, Wilson J, Taylor L, Brierley E, Johnson M, Turnbull D . A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am J Hum Genet. 1997; 60(2):373-80. PMC: 1712391. View

Schon E, Bonilla E, DiMauro S . Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr. 1997; 29(2):131-49. DOI: 10.1023/a:1022685929755. View

Howell N . mtDNA recombination: what do in vitro data mean?. Am J Hum Genet. 1997; 61(1):19-22. PMC: 1715851. DOI: 10.1086/513910. View

Lightowlers R, Chinnery P, Turnbull D, Howell N . Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet. 1998; 13(11):450-5. DOI: 10.1016/s0168-9525(97)01266-3. View

Chinnery P, Turnbull D . Clinical features, investigation, and management of patients with defects of mitochondrial DNA. J Neurol Neurosurg Psychiatry. 1998; 63(5):559-63. PMC: 2169824. DOI: 10.1136/jnnp.63.5.559. View

Brierley E, Johnson M, Lightowlers R, James O, Turnbull D . Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann Neurol. 1998; 43(2):217-23. DOI: 10.1002/ana.410430212. View

10.

Turnbull D, Lightowlers R . An essential guide to mtDNA maintenance. Nat Genet. 1998; 18(3):199-200. DOI: 10.1038/ng0398-199. View

11.

Larsson N, Wang J, Wilhelmsson H, Oldfors A, Rustin P, Lewandoski M . Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet. 1998; 18(3):231-6. DOI: 10.1038/ng0398-231. View

12.

Gross N, Getz G, Rabinowitz M . Apparent turnover of mitochondrial deoxyribonucleic acid and mitochondrial phospholipids in the tissues of the rat. J Biol Chem. 1969; 244(6):1552-62. View

13.

Flory Jr P, Vinograd J . 5-bromodeoxyuridine labeling of monomeric and catenated circular mitochondrial DNA in HeLa cells. J Mol Biol. 1973; 74(2):81-94. DOI: 10.1016/0022-2836(73)90100-9. View

14.

Mita S, Schmidt B, Schon E, DiMauro S, Bonilla E . Detection of "deleted" mitochondrial genomes in cytochrome-c oxidase-deficient muscle fibers of a patient with Kearns-Sayre syndrome. Proc Natl Acad Sci U S A. 1989; 86(23):9509-13. PMC: 298526. DOI: 10.1073/pnas.86.23.9509. View

15.

Shoubridge E, Karpati G, Hastings K . Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease. Cell. 1990; 62(1):43-9. DOI: 10.1016/0092-8674(90)90238-a. View

16.

Larsson N, Holme E, Kristiansson B, Oldfors A, Tulinius M . Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res. 1990; 28(2):131-6. DOI: 10.1203/00006450-199008000-00011. View

17.

Hayashi J, Ohta S, Kikuchi A, Takemitsu M, Goto Y, Nonaka I . Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci U S A. 1991; 88(23):10614-8. PMC: 52980. DOI: 10.1073/pnas.88.23.10614. View

18.

Wallace D . Diseases of the mitochondrial DNA. Annu Rev Biochem. 1992; 61:1175-212. DOI: 10.1146/annurev.bi.61.070192.005523. View

19.

Boulet L, Karpati G, Shoubridge E . Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet. 1992; 51(6):1187-200. PMC: 1682926. View

20.

Moraes C, Ricci E, Petruzzella V, Shanske S, DiMauro S, Schon E . Molecular analysis of the muscle pathology associated with mitochondrial DNA deletions. Nat Genet. 1992; 1(5):359-67. DOI: 10.1038/ng0892-359. View